Ark Biotech

Ark Biotech

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://arkbiotech.com/

Last Round

VC Round

May 24, 2024

Total Funding Raised

$2.5M

Company Overview

Ark Biotech is a business/productivity software company that develops a high-fidelity bioprocess simulation software to accelerate time to market and increase throughput for biopharmaceutical companies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Vertical SaaS, Medical AI, Smart Manufacturing

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

bioprocess simulationin-silico simulationdigital twinbioprocess digital twincontract development and manufacturing organizationsCDMOshybrid modelingmechanistic modelingbioprocessing optimizationcell culture simulationbioreactor simulationtech transferbioprocess scale-upVertical SaaSMedical AIno-code platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ark Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ark Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 24, 2024
AcceleratorOct 24, 2022
SeedDec 16, 2021

Ark Biotech Investors

Notable investors and investment history

InvestorRounds
The EngineAccelerator, VC Round
Hawktail ManagementVC Round
HCVCVC Round
Lowercase CapitalVC Round
Night CapitalVC Round
Primary Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 24, 2024

    $8.2M raised from Hawktail Management, HCVC, and others.

  • Oct 24, 2022

    The Engine led the accelerator round.

Ark Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ark Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ark Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2021
Last FundingMay 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.